These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 22445991)

  • 1. [Slow-release recombinant human bone morphogenetic protein-2 suppresses chromium wear particle-induced osteolysis in rats].
    Li G; Li Q; Lin LJ; Duan X; Zhang XQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):391-5. PubMed ID: 22445991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of polyethylene particle-induced osteolysis by exogenous osteoprotegerin.
    von Knoch F; Heckelei A; Wedemeyer C; Saxler G; Hilken G; Brankamp J; Sterner T; Landgraeber S; Henschke F; Löer F; von Knoch M
    J Biomed Mater Res A; 2005 Nov; 75(2):288-94. PubMed ID: 16088891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of dose on rhBMP-2 signaling, delivered via collagen sponge, on osteoclast activation and in vivo bone resorption.
    Kim RY; Oh JH; Lee BS; Seo YK; Hwang SJ; Kim IS
    Biomaterials; 2014 Feb; 35(6):1869-81. PubMed ID: 24321706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interleukin-4 and osteoprotegerin suppress polyethylene wear debris-induced osteolysis in a murine air pouch model].
    Wang Y; Zhou R; Wu NN; Mou YQ; Li RD; Deng ZL
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1709-13. PubMed ID: 22027773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of aseptic loosening by receptor activator of nuclear factor kappa B ligand antibody in osteolysis model of mouse].
    Zhao S; Cheng T; Peng X; Zhang X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 Jun; 25(6):656-60. PubMed ID: 21735775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibitory effects of vascular endothelial growth factor antibody on wear particle-induced osteolysis].
    Dai M; Zhong Y; Zong L; Yang X; Cheng M; Yang K
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 Jun; 26(6):647-51. PubMed ID: 22792755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with BMP-2 and a systemic RANKL inhibitor enhances bone healing in a mouse critical-sized femoral defect.
    Bougioukli S; Jain A; Sugiyama O; Tinsley BA; Tang AH; Tan MH; Adams DJ; Kostenuik PJ; Lieberman JR
    Bone; 2016 Mar; 84():93-103. PubMed ID: 26723577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model.
    Yang SY; Mayton L; Wu B; Goater JJ; Schwarz EM; Wooley PH
    Arthritis Rheum; 2002 Sep; 46(9):2514-23. PubMed ID: 12355500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of inflammatory cytokines, RANKL and OPG induced by titanium, cobalt-chromium and polyethylene particles.
    Masui T; Sakano S; Hasegawa Y; Warashina H; Ishiguro N
    Biomaterials; 2005 May; 26(14):1695-702. PubMed ID: 15576143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melittin Treats Periprosthetic Osteolysis in a Rat Model by Inhibiting the NF-kB Pathway and Regulating the Ratio of Receptor Activator of Nuclear Factor Kappa B Ligand/Osteoprotegerin.
    Niu J; Bi F; Tian Q; Tian K
    J Arthroplasty; 2024 Jul; 39(7):1845-1855. PubMed ID: 38336308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of recombinant human bone morphogenetic protein-2, -4, and -7 on bone formation in rat calvarial defects.
    Hyun SJ; Han DK; Choi SH; Chai JK; Cho KS; Kim CK; Kim CS
    J Periodontol; 2005 Oct; 76(10):1667-74. PubMed ID: 16253088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis.
    Goater JJ; O'Keefe RJ; Rosier RN; Puzas JE; Schwarz EM
    J Orthop Res; 2002 Mar; 20(2):169-73. PubMed ID: 11918293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of human recombinant bone morphogenetic protein-2 to inactive commercial human demineralized freeze-dried bone allograft makes an effective composite bone inductive implant material.
    Schwartz Z; Somers A; Mellonig JT; Carnes DL; Wozney JM; Dean DD; Cochran DL; Boyan BD
    J Periodontol; 1998 Dec; 69(12):1337-45. PubMed ID: 9926763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed onset of paralysis and slowed tumor growth following in situ placement of recombinant human bone morphogenetic protein 2 within spine tumors in a rat model of metastatic breast cancer.
    Molina CA; Sarabia-Estrada R; Gokaslan ZL; Witham TF; Bydon A; Wolinsky JP; Sciubba DM
    J Neurosurg Spine; 2012 Apr; 16(4):365-72. PubMed ID: 22264176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of rhBMP-2 sustained-release nanocapsules on the ectopic osteogenesis process in Sprague-Dawley rats.
    Lai RF; Li ZJ; Zhou ZY; Feng ZQ; Zhao QT
    Asian Pac J Trop Med; 2013 Nov; 6(11):884-8. PubMed ID: 24083584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of varying the particle size of beta tricalcium phosphate carrier of recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects.
    Jung UW; Choi SY; Pang EK; Kim CS; Choi SH; Cho KS
    J Periodontol; 2006 May; 77(5):765-72. PubMed ID: 16671867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.
    Quinn JM; Itoh K; Udagawa N; Hausler K; Yasuda H; Shima N; Mizuno A; Higashio K; Takahashi N; Suda T; Martin TJ; Gillespie MT
    J Bone Miner Res; 2001 Oct; 16(10):1787-94. PubMed ID: 11585342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of recombinant human bone morphogenetic protein-4 dose on bone formation in a rat calvarial defect model.
    Pang EK; Im SU; Kim CS; Choi SH; Chai JK; Kim CK; Han SB; Cho KS
    J Periodontol; 2004 Oct; 75(10):1364-70. PubMed ID: 15562914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic protein-binding peptide reduces the inflammatory response to recombinant human bone morphogenetic protein-2 and recombinant human bone morphogenetic protein-7 in a rodent model of soft-tissue inflammation.
    Lee KB; Murray SS; Taghavi CE; Song KJ; Brochmann EJ; Johnson JS; Keorochana G; Liao JC; Wang JC
    Spine J; 2011 Jun; 11(6):568-76. PubMed ID: 21729805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Concentration- or time-dependent manner of recombinant bone morphogenetic protein 2 in regulating expression of vascular endothelial growth factor].
    Cao X; Chen H; Cui Z; Jin G; Yang Y; Wang Y; Xiao W
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Aug; 27(8):904-9. PubMed ID: 24171342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.